We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Israeli Drugmaker Picks Up Allergan’s Generics Division
Israeli Drugmaker Picks Up Allergan’s Generics Division
Less than a day after finalizing its acquisition of Allergan’s generics division, Israeli drugmaker Teva Pharmaceutical disclosed plans to pick up the company’s distribution arm for $500 million.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor